Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Voltari Corporation (VLTC) Message Board

Voltari Corp. (Nasdaq:VLTC) Under Carl Icahn Umbrella

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 54
Posted On: 04/01/2015 4:29:14 AM
Posted By: riddock57
The price of Voltari Corporation (Nasdaq:VLTC) stock more than doubled in the extended session Tuesday after billionaire investor Carl Icahn disclosed in a filing with the Securities and Exchange Commission that he recently acquired 4.06 million shares of VLTC at a price of $1.36.

Carl Icahn now owns 4.74 million shares of VLTC, representing a 52.3% stake in the company

VLTC is a digital advertising company dedicated to helping companies get the most out of their marketing budgets and the lifetime value of their customers

More about Voltari Corporation (VLTC) at www.voltari.com

**

Shares of Dyax Corp. (DYAX) soared in after-hours trading on Tuesday, after the company reported positive results from an ongoing Phase 1b clinical study designed to assess the safety, tolerability and pharmacokinetics of DX-2930 in patients with hereditary angioedema (HAE), a rare acute inflammatory condition characterized by episodes of severe, often painful swelling affecting the extremities, gastrointestinal tract, genitalia, and larynx.

DYAX's DX-2930 is a fully human monoclonal antibody inhibitor of plasma kallikrein being developed for the prevention of HAE attacks.

According to DYAX, DX-2930 was well tolerated at all dose levels, the study met all of its primary objectives, and notably, DX-2930 also demonstrated statistically significant reductions in HAE attack rate compared to placebo, an important characteristic for a prophylactic treatment.

DYAX also announced receipt of Fast Track designation from the U.S. Food and Drug Administration (FDA) for the investigation of DX-2930 for HAE attacks.

DYAX is a fully integrated biopharmaceutical company focused on the development and commercialization of novel biotherapeutics for unmet medical needs.

More about Dyax Corp. (DYAX) at www.dyax.com

**

Crown Equity Holdings Inc. (CRWE) is currently developing its CRWE Network ( www.CRWE-PR.com ), a growing network of community targeted sites.

It has recently included the City of Merced, CA ( www.merced.crwe-pr.com ) into the CRWE Network.

Merced, county seat of Merced County, is situated in the San Joaquin Valley of Central California. Traditionally reliant on agriculture, the city's economy also benefited from the presence of Castle Air Force Base until its closure in 1995. Industrial development is increasing in the area.

The City of Merced had an estimated population in 2013 (U.S. Census Bureau) of 81,102, and represents an important marketplace for the CRWE Network, which business model is based on selling advertising to businesses targeting both locally and nationally

The CRWE Network has reached the 1487th community website in the U.S. and includes coverage in the states of California, Mississippi, Michigan, Florida, Nevada and New York, as well as across 10 provinces in Canada.

The company’s CRWE Real Estate ( www.CRWERealEstate.com ) is expected to be integrated in all the CRWE Network. It will allow people to submit their listings for exposure to visitors searching for homes.

CRWE provides marketing solutions that boost customer awareness and merchant visibility on the Internet.

More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com

**

Disclaimer: CRWE-PR Finance is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read Full Disclaimer at CRWE-PR Finance www.finance.crwe-pr.com/disclaimer


(0)
(0)




Voltari Corporation (VLTC) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us